ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $18,000 | +157.1% | 196 | +67.5% | 0.00% | +100.0% |
Q3 2021 | $7,000 | -50.0% | 117 | -40.9% | 0.00% | 0.0% |
Q2 2021 | $14,000 | +180.0% | 198 | +153.8% | 0.00% | 0.0% |
Q1 2021 | $5,000 | +150.0% | 78 | +239.1% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 23 | +53.3% | 0.00% | – |
Q3 2020 | $1,000 | – | 15 | +400.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 3 | -78.6% | 0.00% | – |
Q4 2019 | $1,000 | – | 14 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |